PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Wednesday-Friday, February 9–11. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Pri-Med has more virtual education planned. View the schedule here.

Plan Your CME/CE Experiences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Hot Topics

Curbside Consults: Top Questions from PCPs on Menopause and Arthritis

Jan L. Shifren, MD | Peng Thim Fan, MD, FACP

 

What do primary care providers need to know about menopause and arthritis? Join expert faculty as they review important questions they get asked about these topics!

Jan L. Shifren, MD

Director, Midlife Women’s Health Center, Massachusetts General Hospital, Vincent Trustees Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA

Peng Thim Fan, MD, FACP

Clinical Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

9:10–10:10am ET    CME/CE Accredited Session

Hot Topics

Challenging Cases in Primary Care

Pamela Kushner, MD, FAAFP

 

In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.

Pamela Kushner, MD, FAAFP

Clinical Professor, University of California Irvine Medical Center Director, Kushner Wellness Center, Los Alamitos, CA

10:20–11:05am ET    Non-CME Industry Theater

Cardiology

David Wolinsky, MD, FACC, MASNC

 

This Product Theater Presentation focuses on providing education to Frontline Providers on the topics of CAD risk assessment, the various testing modalities available, the value of SPECT MPI, and the Appropriate Use Criteria (AUC).

David Wolinsky, MD, FACC, MASNC

Head of Nuclear Cardiology, Cleveland Clinic, Florida

Sponsored by Astellas Pharma U.S., Inc.

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

COPD: New for 22

Corinne R. Young, MSN, FNP-C, FCCP | Justin Hovey, M.D., FAAP

 

This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.

Corinne R. Young, MSN, FNP-C, FCCP

Nurse Practitioner, Director of APP and Clinical Services, Study Coordinator, Colorado Springs Pulmonary Consultants, PC

Justin Hovey, M.D., FAAP

President, Internal Medicine and Pediatric Consultants, P.C.

Sponsored by GlaxoSmithKline

11:15am–12:15pm ET    CME/CE Accredited Session

Gastroenterology

Managing Myths and Misconceptions about Chronic Idiopathic Constipation and Irritable Bowel Syndrome with Constipation

Philip Schoenfeld, MD, MSEd, MSc

 

This activity will provide an evidence-based approach to the diagnosis and management of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with minimal diagnostic testing. The faculty will describe evidence-based treatment guidelines and discuss the efficacy of over-the-counter and prescription agents prioritized within the guidelines. This will help you navigate the progress from patient education to diet plus over-the-counter agents to prescription agents.

Philip Schoenfeld, MD, MSEd, MSc

Chief (Emeritus) - Gastroenterology Section, John D. Dingell VA Medical Center, Detroit, MI

Supported by an educational grant from AbbVie Inc. and Takeda Pharmaceuticals U.S.A., Inc..

12:25–1:25pm ET    CME/CE Accredited Session

Endocrinology

Cardiometabolic Panel Discussion: Making Sense of New Guideline Updates

Archana R. Sadhu, MD, FACE | Ty J. Gluckman, MD, FACC, FAHA

 

Do you want to provide the most up-to-date, evidence-based care for your patients with cardiometabolic disease? Then you won’t want to miss this session that provides an overview of updated clinical practice guidelines for the treatment of hypertriglyceridemia and type 2 diabetes followed by an opportunity to have all your questions answered!

Archana R. Sadhu, MD, FACE

Director, System Diabetes Program at Houston Methodist,, Assistant Clinical Professor, Weill Cornell Medical College, Adjunct Assistant Professor, Texas A&M Health Sciences

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

1:35–2:20pm ET    Non-CME Industry Theater

Cardiology

Clinical Insights in VTE: Treatment and Reduction in the Risk of Recurrent DVT/PE

Justin Trivax, MD, FACC, FSCAI

 

This lecture will discuss the Treatment and reduction in the risk of recurrent DVT/PE, whether initiated in the inpatient or outpatient setting.

Justin Trivax, MD, FACC, FSCAI

Millennium Cardiology, A Division of Michigan Healthcare Professionals , Clinical Faculty, Department of Cardiovascular Medicine, Beaumont Hospital Royal Oak , Assistant Professor, Oakland University William Beaumont School of Medicine , Clinical Assistant Professor, Wayne State University School of Medicine, Co-Founder, Hearts for Heroes

Sponsored by Janssen Pharmaceuticals, Inc.

1:35–2:20pm ET    Non-CME Industry Theater

Rheumatology

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Christopher Parker, DO

 

  • Understand the causes and prevalence of chronic low back pain.
  • Differentiate inflammatory back pain (IBP) from mechanical back pain.
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS).
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner.

Christopher Parker, DO

Sponsored by AbbVie Inc.

2:30–3:30pm ET    CME/CE Accredited Session

Infectious Disease

COVID-19 Panel Discussion (February 2022)

Daniel A. Solomon, MD | Laila Woc-Colburn, MD

 

This pandemic requires communication among specialists and primary care clinicians. In this COVID-19 panel, expert faculty will team up to discuss the most pressing and frequently asked questions about the disease and its complications.

Daniel A. Solomon, MD

Associate Physician, Division of Infectious Diseases
Brigham and Women's Hospital
Instructor of Medicine,
Harvard Medical School
Boston, MA

Laila Woc-Colburn, MD

Associate Professor, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA

3:40–4:40pm ET    CME/CE Accredited Session

Urgent Care

Curbside Consults: Top Questions from PCPs on Care of the Patient with Cellulitis and Chest Pain

Howard Libman, MD | Ty J. Gluckman, MD, FACC, FAHA

 

What do primary care providers need to know about cellulitis care and chest pain? Join expert faculty as they review important questions they get asked about these topics!

Howard Libman, MD

Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

4:50–5:35pm ET    Non-CME Industry Theater

Endocrinology

Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?

Jeff Unger, MD, FAAFP, FACE

 

Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.

Jeff Unger, MD, FAAFP, FACE

Diplomate, American Board of Family Practice, Assistant Clinical Professor of Family Medicine, UC Riverside School of Medicine, Riverside, California, Director, Unger Concierge Primary Care Medical Group, Rancho Cucamonga, California

Sponsored by Novo Nordisk

8–11:30am ET    CME/CE Accredited Session

Pain

Strategies for Effective Pain Management in Clinical Practice

Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP

 

The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management in Clinical Practice curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including nonopioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

11:40am–12:25pm ET    Non-CME Industry Theater

Gastroenterology

Treating EPI: EPI in Clinical Practice

Douglas Adler, MD

 

Discuss the diagnosis of Exocrine Pancreatic Insufficiency (EPI) and the treatment with CREON.

Douglas Adler, MD

Porter Adventist Hospital, Centura Health

Sponsored by AbbVie Inc.

12:35–1:35pm ET    CME/CE Accredited Session

Neurology

What Primary Care Clinicians Need to Know About Alzheimer’s Disease: Early Diagnosis, Patient-Specific Management, and Care Collaboration

Richard S. Isaacson, MD | Charles Vega, MD, FAAFP

 

Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on. 

This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.

Richard S. Isaacson, MD

Director, Center for Brain Health, Director, Alzheimer’s Prevention Clinic, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, Adjunct Associate Professor of Neurology, Department of Neurology, Weill Cornell Medicine/NewYork-Presbyterian, New York City, NY

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by Eisai

1:45–2:45pm ET    CME/CE Accredited Session

Rheumatology

 

Sjögren’s disease (SjD) is one of the most prevalent, yet underdiagnosed autoimmune diseases. Most patients see numerous physicians in many different specialties and over months to years after symptoms first appear prior to getting an accurate diagnosis. Many are misdiagnosed with other disorders during this journey. Most patients with SjD present to their primary care provider (PCP) prior to seeing specialists, such as rheumatologists. PCPs could screen for and diagnose patients with SjD at a higher rate and expedite the time to an accurate diagnosis and hence provide much needed and effective treatments that can greatly improve their quality of life. Extraglandular complications affect most patients, proving that SjD is much more than “dry eyes and dry mouth.” PCPs are in a prime position to help identify patients with these complications and assist with proper management and referrals to the appropriate specialists. The participant in this PrimaryCareNOW course will learn the most up to date information about SjD, its diagnosis, and its treatment options. The participant will also have the opportunity to have a Q&A session with Dr. Thomas.

Donald E. Thomas, MD

Chair, National Board of Directors
of the Sjogren's Foundation

2:55–3:40pm ET    Non-CME Industry Theater

Dermatology

The Impact and Management of Moderate-to-Severe Atopic Dermatitis in Appropriate Patients

Jennifer Soung, MD, FAAD

 

Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your appropriate patients and a treatment option that may help them.

Jennifer Soung, MD, FAAD

Director of Clinical Research, Southern California Dermatology, Santa Ana, California

Sponsored by Regeneron and Sanofi Genzyme

3:50–4:50pm ET    CME/CE Accredited Session

Psychiatry

Psychopharmacology: Prescribing with Confidence 

Jeffrey Rado, MD, MPH, FAPA

 

What do primary care providers need to know about psychopharmacology to treat major depressive disorder and anxiety? Join Dr. Jeffrey Rado as he reviews important concepts that can help you improve the care of your patients. 

Jeffrey Rado, MD, MPH, FAPA

Associate Professor, Northwestern Feinberg School of Medicine, Chicago, IL

5–5:45pm ET    Non-CME Industry Theater

Cardiology

Addressing Elevated Risk for Thrombotic CV Events in Patients Across the CAD Spectrum

Victor Howard, MD, FACC

 

  • Understand the risk factors that contribute to the elevated risk for thrombotic cardiovascular events pre- and post-myocardial infarction in patients across the coronary artery disease spectrum.
  • Differentiate oral P2Y12 inhibitors with respect to their clinical pharmacology and examine the select differences between oral antiplatelet therapies.
  • Describe the role of BRILINTA in reducing the risk of cardiovascular events in patients with acute coronary syndrome, history of myocardial infarction, and high-risk coronary artery disease without prior myocardial infarction.

Victor Howard, MD, FACC

AstraZeneca Pharmaceuticals, LP

Sponsored by AstraZeneca Pharmaceuticals, LP

8–9am ET    CME/CE Accredited Session

Hot Topics

Challenging Diagnostic Dilemmas in Primary Care

Howard Libman, MD

 

In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.

Howard Libman, MD

Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA

9:10–10:10am ET    CME/CE Accredited Session

Infectious Disease

Bridging the Gap: Strategies for Ending the HIV Epidemic 

Demetre C. Daskalakis, MD, MPH | Gregory L. Hall, MD

 

As part of its partnership with the Centers for Disease Control and Prevention’s Let’s Stop HIV Together campaign, Dr. Demetre Daskalakis, Director of the Division of HIV Prevention, will join Pri-Med faculty  Dr. Greg Hall, expert in African American health and healthcare, as they discuss strategies for stopping the HIV epidemic across all communities. In this session, you’ll explore the concept of HIV as a syndemic and how that framework can help you identify patients with risk factors for HIV. You’ll also learn the importance of applying a status neutral approach to HIV care to ensure effective treatment and prevention of HIV across all patient populations. You’ll also leave the session with information on the latest guidelines and recommendations, including the newly released guidelines on HIV prevention with PrEP.  It’s a can’t-miss educational opportunity for anyone looking for practical tools to help your patients and help end the HIV epidemic. 

Demetre C. Daskalakis, MD, MPH

Director, Division of HIV/AIDS Prevention (DHAP), Centers for Disease Control and Prevention , Atlanta, GA

Gregory L. Hall, MD

Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

10:20–11:05am ET    Non-CME Industry Theater

Endocrinology

 

Copyright © 2022 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. (02/22) EM-US-102145

Please see accompanying JARDIANCE Prescribing Information and JARDIANCE Medication Guide 

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

11:15am–12:15pm ET    CME/CE Accredited Session

Wellness

Nutrition Tips for Primary Care: Strategies from a Dietician Beyond the Basics

Bethany Doerfler, MS, RDN

 

Nutrition research and recommendations are rapidly changing. Fill your toolbox with behavioral and food-driven action plans to answer your patients' toughest nutrition and lifestyle issues. Updated recommendations for nutrition advice for IBS, intermittent fasting, popular diets, food intolerances, and more will be answered.

Bethany Doerfler, MS, RDN

Senior Clinical Research Dietitian, Northwestern University, Feinberg School of Medicine, Adjunct Faculty, Marciella School of Nursing, Loyola University, Chicago, IL

12:25–1:25pm ET    CME/CE Accredited Session

Cardiology

Cardiovascular Disease and Women 

Karol E. Watson, MD, PhD

 

Heart disease is the leading cause of death for women, and the pathophysiology, prevention strategies, screening, and treatments are often different from men. This session will discuss differences and similarities in heart disease between women and men and offer recommendations for prevention, evaluation, and treatment.

Karol E. Watson, MD, PhD

Professor of Medicine/Cardiology, Co-director, UCLA Program in Preventive Cardiology, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA

1:35–2:20pm ET    Non-CME Industry Theater

Gastroenterology

A Proactive Way to Treat IBS-D: Post-Marketing Information and Phase 4 Data

Kimberly Orleck, PA

 

Please join us in a clinical review of exciting Phase 4 data and the latest post-marketing information on a proactive treatment that may help your IBS-D patients. IBS-D is a chronic functional disorder of the GI system that affects approximately 16 million people. 

Kimberly Orleck, PA

Atlanta Gastroenterology Associates

Sponsored by AbbVie Inc.

2:30–3:30pm ET    CME/CE Accredited Session

Hepatology

Fatty Liver Manifestation of the Metabolic Syndrome: Diagnosis, Natural History, and Treatment

Sammy Saab, MD, MPH, AGAF

 

Fatty liver has emerged as a major health concern in the United States. It is now one of the leading causes of cirrhosis, risk factor for liver cancer and indication for liver transplantation. This session will help clinicians to understand the epidemiology and risk factors of fatty liver as well as how to tailor medical care in patients with underlying fatty liver disease.

Sammy Saab, MD, MPH, AGAF

Professor, Medicine and Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, Head, Outcomes Research in Hepatology, David Geffen School of Medicine at UCLA, Los Angeles, CA

3:40–4:40pm ET    CME/CE Accredited Session

Dermatology

Dermatology A-Z: A Refresher for Primary Care 

Daniela Kroshinsky, MD, MPH

 

This session will provide an update on common skin disorders including diagnosis and management of papulosquamous disorders, medication reactions, skin infections, and melanocytic lesions.

Daniela Kroshinsky, MD, MPH

Associate Professor of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

4:50–5:35pm ET    Non-CME Industry Theater

Cardiovascular Medicine

“It’s the Little Things”: A Tale of Two Patients

Abena Osei-Wusu, MD, FACC, FSCAI | Mark Stampehl, MD, FACC, FHFSA

 

This video follows two patients on their cardiovascular disease journeys. Risk factors leading to the development and progression of atherosclerotic cardiovascular disease and heart failure are discussed in the context of the patient experience over time. Strategies for primary and secondary prevention and optimization of guideline-directed medical therapy are also highlighted. 

Abena Osei-Wusu, MD, FACC, FSCAI

Medical Director, Atherosclerosis, Cardiovascular, Renal & Metabolic Medical Unit, Novartis Pharmaceuticals Corporation

Mark Stampehl, MD, FACC, FHFSA

Executive Medical Director, Cardiovascular, Renal & Metabolic Medical Unit, Novartis Pharmaceuticals Corporation

Sponsored by Novartis Pharmaceuticals Corporation